Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Complement Factor H Haplotypes and Smoking in Age-related Macular Degeneration

Authors not listed

VA Office of Research and Development · 2010

Abstract

Risk factors for Age-related Macular Degeneration (AMD) involves genetic variations in the alternative pathway of complement inhibitor factor H. The complement system is part of the innate and adaptive immune system. Smoking is the only environmental factor known to increase the risk of Age-related Macular Degeneration (AMD). Using serum samples of Age-related Macular Degeneration (AMD) patients and controls the investigators will test the hypothesis that smoking increases Age-related Macular Degeneration (AMD) by increasing complement activation; and that this is positively correlated with known disease variations in the complement factor H (CFH) gene.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-12 MST

Cite this

APA
Anonymous. (2010). Complement Factor H Haplotypes and Smoking in Age-related Macular Degeneration. <em>VA Office of Research and Development</em>. https://clinicaltrials.gov/study/NCT01115231
Vancouver
Anonymous. Complement Factor H Haplotypes and Smoking in Age-related Macular Degeneration. VA Office of Research and Development. 2010.
BibTeX
@misc{anon2010Comple, title = {Complement Factor H Haplotypes and Smoking in Age-related Macular Degeneration}, author = {Anonymous}, journal = {VA Office of Research and Development}, year = {2010}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings